Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-03-22 @ 12:22 PM
Study NCT ID:
NCT01005251
Status:
COMPLETED
Last Update Posted:
2011-04-25
First Post:
2009-10-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D9120C00019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
MSD
Old Organization:
AstraZeneca